Eksioglu-Demiralp E, Direskeneli H, Ergun T, Fresko I, Akoglu T
Kosuyolu Cad, Kadikoy, Istanbul, Turkey.
Rheumatol Int. 1999;19(1-2):23-6. doi: 10.1007/s002960050094.
Behçet's disease is a systemic vasculitis of unknown etiology. Various immune abnormalities have previously been shown in Behçet's disease. We investigated T lymphocyte subsets associated with cytotoxic activity and natural killer (NK) cells by flow cytometry in 37 patients with Behçet's disease, 38 healthy controls, and 17 diseased control patients. Compared to the healthy controls, CD4+CD16+ and CD4+CD56+ subsets were found to be higher in the Behçet's disease group as well as in the disease control group (CD4+CD16+: BD = 5 +/- 3, DC = 14 +/- 14, HC = 3 +/- 2, P = 0.001; CD4+CD56+: BD = 11 +/- 5, DC = 18 +/- 17, HC = 8 +/- 6, P = 0.01). CD8+CD16+ and CD8+CD56+ T cell subsets were at normal levels in Behçet's disease but found to be elevated in disease controls. Similarly, NK cells (CD16+CD56+) were high only in the disease control group. Significant increases in CD4+CD16+ and CD4+CD56+ cell subsets in Behçet's patients and disease controls suggest that T cell activation patterns of these subsets in Behçet's disease are similar to those in other inflammatory disorders.
白塞病是一种病因不明的全身性血管炎。先前已在白塞病中发现各种免疫异常。我们通过流式细胞术研究了37例白塞病患者、38例健康对照者和17例疾病对照患者中与细胞毒性活性相关的T淋巴细胞亚群和自然杀伤(NK)细胞。与健康对照相比,发现白塞病组和疾病对照组中的CD4+CD16+和CD4+CD56+亚群更高(CD4+CD16+:白塞病组 = 5±3,疾病对照组 = 14±14,健康对照组 = 3±2,P = 0.001;CD4+CD56+:白塞病组 = 11±5,疾病对照组 = 18±17,健康对照组 = 8±6,P = 0.01)。CD8+CD16+和CD8+CD56+ T细胞亚群在白塞病中处于正常水平,但在疾病对照组中升高。同样,NK细胞(CD16+CD56+)仅在疾病对照组中较高。白塞病患者和疾病对照组中CD4+CD16+和CD4+CD(此处原文可能有误,推测应为CD4+CD56+)56+细胞亚群的显著增加表明,白塞病中这些亚群的T细胞激活模式与其他炎症性疾病相似。